RhumbLine Advisers’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $244K | Buy |
32,308
+1,168
| +4% | +$8.83K | ﹤0.01% | 3116 |
|
|
2025
Q1 | $172K | Sell |
31,140
-5,951
| -16% | -$32.8K | ﹤0.01% | 3182 |
|
|
2024
Q4 | $213K | Buy |
37,091
+926
| +3% | +$5.32K | ﹤0.01% | 3161 |
|
|
2024
Q3 | $375K | Buy |
36,165
+1,599
| +5% | +$16.6K | ﹤0.01% | 2899 |
|
|
2024
Q2 | $448K | Buy |
34,566
+1,548
| +5% | +$20.1K | ﹤0.01% | 2759 |
|
|
2024
Q1 | $576K | Buy |
33,018
+704
| +2% | +$12.3K | ﹤0.01% | 2575 |
|
|
2023
Q4 | $304K | Sell |
32,314
-166
| -0.5% | -$1.56K | ﹤0.01% | 2962 |
|
|
2023
Q3 | $363K | Sell |
32,480
-32,264
| -50% | -$360K | ﹤0.01% | 2820 |
|
|
2023
Q2 | $1.39M | Buy |
64,744
+882
| +1% | +$18.9K | ﹤0.01% | 2121 |
|
|
2023
Q1 | $2.58M | Buy |
63,862
+3,799
| +6% | +$154K | ﹤0.01% | 1677 |
|
|
2022
Q4 | $2.79M | Buy |
60,063
+60
| +0.1% | +$2.79K | ﹤0.01% | 1615 |
|
|
2022
Q3 | $3.11M | Buy |
60,003
+4,223
| +8% | +$219K | ﹤0.01% | 1516 |
|
|
2022
Q2 | $2.64M | Buy |
55,780
+2,055
| +4% | +$97.2K | ﹤0.01% | 1621 |
|
|
2022
Q1 | $3.82M | Sell |
53,725
-411
| -0.8% | -$29.3K | ﹤0.01% | 1479 |
|
|
2021
Q4 | $4.05M | Sell |
54,136
-1,024
| -2% | -$76.6K | 0.01% | 1484 |
|
|
2021
Q3 | $3.13M | Sell |
55,160
-6,796
| -11% | -$386K | ﹤0.01% | 1636 |
|
|
2021
Q2 | $2.73M | Sell |
61,956
-4,063
| -6% | -$179K | ﹤0.01% | 1792 |
|
|
2021
Q1 | $3.26M | Buy |
66,019
+762
| +1% | +$37.6K | ﹤0.01% | 1651 |
|
|
2020
Q4 | $2.75M | Buy |
65,257
+5,698
| +10% | +$240K | ﹤0.01% | 1686 |
|
|
2020
Q3 | $2.73M | Sell |
59,559
-2,084
| -3% | -$95.4K | ﹤0.01% | 1521 |
|
|
2020
Q2 | $3.1M | Buy |
61,643
+3,714
| +6% | +$186K | 0.01% | 1473 |
|
|
2020
Q1 | $2.98M | Buy |
57,929
+3,820
| +7% | +$196K | 0.01% | 1332 |
|
|
2019
Q4 | $3.34M | Buy |
54,109
+3,220
| +6% | +$199K | 0.01% | 1501 |
|
|
2019
Q3 | $3.06M | Buy |
50,889
+1,214
| +2% | +$72.9K | 0.01% | 1483 |
|
|
2019
Q2 | $4.19M | Buy |
49,675
+2,777
| +6% | +$234K | 0.01% | 1297 |
|
|
2019
Q1 | $4.48M | Buy |
46,898
+145
| +0.3% | +$13.9K | 0.01% | 1241 |
|
|
2018
Q4 | $3.31M | Buy |
46,753
+8,722
| +23% | +$618K | 0.01% | 1345 |
|
|
2018
Q3 | $3.25M | Buy |
38,031
+481
| +1% | +$41.1K | 0.01% | 1384 |
|
|
2018
Q2 | $4.35M | Buy |
37,550
+691
| +2% | +$80.1K | 0.01% | 1192 |
|
|
2018
Q1 | $2.98M | Buy |
36,859
+384
| +1% | +$31.1K | 0.01% | 1373 |
|
|
2017
Q4 | $2.14M | Buy |
36,475
+4,476
| +14% | +$263K | ﹤0.01% | 1583 |
|
|
2017
Q3 | $1.5M | Buy |
31,999
+870
| +3% | +$40.7K | ﹤0.01% | 1772 |
|
|
2017
Q2 | $1.12M | Sell |
31,129
-176
| -0.6% | -$6.33K | ﹤0.01% | 1898 |
|
|
2017
Q1 | $964K | Buy |
31,305
+7,781
| +33% | +$240K | ﹤0.01% | 1939 |
|
|
2016
Q4 | $788K | Sell |
23,524
-1,781
| -7% | -$59.7K | ﹤0.01% | 1982 |
|
|
2016
Q3 | $673K | Buy |
25,305
+965
| +4% | +$25.7K | ﹤0.01% | 2035 |
|
|
2016
Q2 | $537K | Buy |
24,340
+5,974
| +33% | +$132K | ﹤0.01% | 2151 |
|
|
2016
Q1 | $539K | Buy |
18,366
+110
| +0.6% | +$3.23K | ﹤0.01% | 2173 |
|
|
2015
Q4 | $603K | Buy |
18,256
+1,525
| +9% | +$50.4K | ﹤0.01% | 2127 |
|
|
2015
Q3 | $605K | Buy |
16,731
+2,078
| +14% | +$75.1K | ﹤0.01% | 2105 |
|
|
2015
Q2 | $659K | Buy |
14,653
+4,640
| +46% | +$209K | ﹤0.01% | 2145 |
|
|
2015
Q1 | $307K | Buy |
10,013
+1,800
| +22% | +$55.2K | ﹤0.01% | 2597 |
|
|
2014
Q4 | $418K | Sell |
8,213
-450
| -5% | -$22.9K | ﹤0.01% | 2382 |
|
|
2014
Q3 | $343K | Sell |
8,663
-540
| -6% | -$21.4K | ﹤0.01% | 2450 |
|
|
2014
Q2 | $396K | Buy |
+9,203
| New | +$396K | ﹤0.01% | 2418 |
|